Skip to main content
. Author manuscript; available in PMC: 2013 Apr 24.
Published in final edited form as: AIDS. 2012 Apr 24;26(7):833–841. doi: 10.1097/QAD.0b013e328351a521

Table 2.

Individual Predicted Median NVP Pharmacokinetic Parameters from the Final Model (n=359)

NVP PK Week 2 (IQR)* Week 4 (IQR)* p-value**
CL/F(L/hr) 1.6 (1.4, 1.8) 2.0 (1.8, 2.3) <0.001
AUC24 hr (mcg*hr/mL) 124.2 (109.0, 144.7) 200.9 (174.4, 227.5) <0.001
Cmin (mcg/mL) 4.0 (3.4, 4.8) 7.2 (6.1, 8.3) <0.001
Cmax (mcg/mL) 6.3 (5.7, 7.2) 9.3 (8.2, 10.4) <0.001
*

IQR= Interquartile range

**

Wilcoxon signed rank test

CL/F = oral clearance

AUC24 = steady state 24 hr area under the curve

Cmin = minimum plasma concentrations

Cmax= maxiumum plasma concentrations